osimertinibdurvalumabpembrolizumabalectinib
…state health sector in which several novel cancer drugs such as osimertinib, alectinib and immunotherapy are not approved for use in advanc…
4articles mentioning drugs
25drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: alectinib ×
alectinib
This drug is selected. Its supporting articles are shown below.
Articles mentioning alectinib
4 articles · page 1 of 1pembrolizumabbortezomibcrizotinibpembrolizumab35sunitinibdasatinib
…umab) are often used in ovarian and cervical cancers. ICIs (eg, pembrolizumab) are effective in mismatch repair-deficient endometrial cancer …
osimertinibcrizotinibsotorasibatezolizumabdurvalumablorlatinibosimertinib-treated
…ring may help identify patients who could benefit from extended osimertinib therapy, although further clinical validation is warranted.ctDN…
osimertinibnintedanibalectinibNSCLCnon-small-cell lung cancerquaternary-care hospital
…ge of 74.5 years. The most frequently prescribed therapies were osimertinib (n=24), alectinib (n=9), and nintedanib (n=5). At baseline, 84%…